233 related articles for article (PubMed ID: 21398051)
1. Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients.
Finkelstein SE; Iclozan C; Bui MM; Cotter MJ; Ramakrishnan R; Ahmed J; Noyes DR; Cheong D; Gonzalez RJ; Heysek RV; Berman C; Lenox BC; Janssen W; Zager JS; Sondak VK; Letson GD; Antonia SJ; Gabrilovich DI
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):924-32. PubMed ID: 21398051
[TBL] [Abstract][Full Text] [Related]
2. Case Report:
Huang JW; Kuo CL; Wang LT; Ma KS; Huang WY; Liu FC; Yang KD; Yang BH
Front Immunol; 2021; 12():752563. PubMed ID: 35003064
[TBL] [Abstract][Full Text] [Related]
3. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
[TBL] [Abstract][Full Text] [Related]
4. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral talimogene laherparepvec injection with concurrent preoperative radiation in patients with locally advanced soft-tissue sarcoma of the trunk and extremities: phase IB/II trial.
Monga V; Miller BJ; Tanas M; Boukhar S; Allen B; Anderson C; Stephens L; Hartwig S; Varga S; Houtman J; Wang L; Zhang W; Jaber O; Thomason J; Kuehn D; Rajput M; Metz C; Zamba KD; Mott S; Abanonu C; Bhatia S; Milhem M
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34330766
[TBL] [Abstract][Full Text] [Related]
6. Perioperative high-dose-rate interstitial brachytherapy combined with external beam radiation therapy for soft tissue sarcoma.
Sharma DN; Deo SV; Rath GK; Shukla NK; Bakhshi S; Gandhi AK; Julka PK
Brachytherapy; 2015; 14(4):571-7. PubMed ID: 25861894
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Clinical Responses of Neoadjuvant Dendritic Cell Infusions and Radiation in Soft Tissue Sarcoma.
Raj S; Bui MM; Springett G; Conley A; Lavilla-Alonso S; Zhao X; Chen D; Haysek R; Gonzalez R; Letson GD; Finkelstein SE; Chiappori AA; Gabrilovitch DI; Antonia SJ
Sarcoma; 2015; 2015():614736. PubMed ID: 26880867
[TBL] [Abstract][Full Text] [Related]
8. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
Ackermann B; Tröger A; Glouchkova L; Körholz D; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(3):176-82. PubMed ID: 15175963
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
[TBL] [Abstract][Full Text] [Related]
10. First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas.
Bonvalot S; Le Pechoux C; De Baere T; Kantor G; Buy X; Stoeckle E; Terrier P; Sargos P; Coindre JM; Lassau N; Ait Sarkouh R; Dimitriu M; Borghi E; Levy L; Deutsch E; Soria JC
Clin Cancer Res; 2017 Feb; 23(4):908-917. PubMed ID: 27998887
[No Abstract] [Full Text] [Related]
11. High-dose-rate intraoperative brachytherapy (IOHDR) using flab technique in the treatment of soft tissue sarcomas.
Rachbauer F; Sztankay A; Kreczy A; Sununu T; Bach C; Nogler M; Krismer M; Eichberger P; Schiestl B; Lukas P
Strahlenther Onkol; 2003 Jul; 179(7):480-5. PubMed ID: 12835885
[TBL] [Abstract][Full Text] [Related]
12. Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma.
Tseng WW; Zhou S; To CA; Thall PF; Lazar AJ; Pollock RE; Lin PP; Cormier JN; Lewis VO; Feig BW; Hunt KK; Ballo MT; Patel S; Pisters PW
Cancer; 2015 Oct; 121(20):3659-67. PubMed ID: 26177983
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma.
Rozera C; Cappellini GA; D'Agostino G; Santodonato L; Castiello L; Urbani F; Macchia I; Aricò E; Casorelli I; Sestili P; Montefiore E; Monque D; Carlei D; Napolitano M; Rizza P; Moschella F; Buccione C; Belli R; Proietti E; Pavan A; Marchetti P; Belardelli F; Capone I
J Transl Med; 2015 May; 13():139. PubMed ID: 25933939
[TBL] [Abstract][Full Text] [Related]
14. Phase 1/2 study of immunotherapy with dendritic cells pulsed with autologous tumor lysate in patients with refractory bone and soft tissue sarcoma.
Miwa S; Nishida H; Tanzawa Y; Takeuchi A; Hayashi K; Yamamoto N; Mizukoshi E; Nakamoto Y; Kaneko S; Tsuchiya H
Cancer; 2017 May; 123(9):1576-1584. PubMed ID: 28241093
[TBL] [Abstract][Full Text] [Related]
15. Interstitial brachytherapy for soft tissue sarcoma: A single institution experience.
Mierzwa ML; McCluskey CM; Barrett WL; Lowy A; Sussman J; Sorger J
Brachytherapy; 2007; 6(4):298-303. PubMed ID: 17959424
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative Electron Radiation Therapy Combined with External Beam Radiation Therapy after Gross Total Resection in Extremity Soft Tissue Sarcoma: A European Pooled Analysis.
Roeder F; de Paoli A; Saleh-Ebrahimi L; Alldinger I; Bertola G; Boz G; Navarria F; Cuervo M; Uhl M; Alvarez A; Buechler M; Lehner B; Debus J; Calvo FA; Krempien R
Ann Surg Oncol; 2018 Dec; 25(13):3833-3842. PubMed ID: 30276647
[TBL] [Abstract][Full Text] [Related]
17. Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma.
Laurell A; Lönnemark M; Brekkan E; Magnusson A; Tolf A; Wallgren AC; Andersson B; Adamson L; Kiessling R; Karlsson-Parra A
J Immunother Cancer; 2017; 5():52. PubMed ID: 28642820
[TBL] [Abstract][Full Text] [Related]
18. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Singer S
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):202-8. PubMed ID: 16111590
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expression.
Omori T; Tazawa H; Yamakawa Y; Osaki S; Hasei J; Sugiu K; Komatsubara T; Fujiwara T; Yoshida A; Kunisada T; Urata Y; Kagawa S; Ozaki T; Fujiwara T
PLoS One; 2021; 16(4):e0250643. PubMed ID: 33886686
[TBL] [Abstract][Full Text] [Related]
20. Interstitial brachytherapy in soft tissue sarcomas: the Rambam experience.
Rosenblatt E; Meushar N; Bar-Deroma R; Drumea K; Stein M; Zidan J; Kuten A
Isr Med Assoc J; 2003 Aug; 5(8):547-51. PubMed ID: 12929290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
